Potential Role of Growth Factors With Particular Focus on Growth Hormone and Insulin-Like Growth Factor-1 in the Management of Chronic Kidney Disease

Seminars in Nephrology

Volumn 29, Issue 1, 2009, Pages 50-58

  Feldt Rasmussen, Bo ^a   El Nahas, Meguid ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Chronic kidney disease; dialysis; growth factors; growth hormone; hemodialysis; IGF 1

Indexed keywords

ANTIANEMIC AGENT; ERYTHROPOIETIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; HUMAN GROWTH HORMONE; OCTREOTIDE; SERUM ALBUMIN; SOMATOMEDIN C; SOMATOSTATIN;

ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE COURSE; ERYTHROPOIESIS; FLUID RETENTION; HEART FUNCTION; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; INFLAMMATION; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; KIDNEY SCAR; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RENAL REPLACEMENT THERAPY; SIDE EFFECT;

ANABOLIC AGENTS; CLINICAL TRIALS AS TOPIC; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FAILURE, CHRONIC; PROTEIN-ENERGY MALNUTRITION;

EID: 58049133260     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2008.10.007     Document Type: Article

References (47)

1. United States Renal Data System. United States Renal Data System annual report. Atlas of end-stage renal disease in the United States (2006), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. Ansell D. Summary of findings in the 2006 UK Renal Registry report (chapter 1). Nephrol Dial Transplant 22 Suppl 7 (2007) vii1-vii2
3. MedSciNet website. [cited 2008 April]. Available from: http://www.medscinet.se/msn/.
4. Danish Society of Nephrology website. [cited 2008 April]. Available from: http://www.nephrology.dk/Index.htm.
5. QuaSi-Niere website. [cited 2008 April]. Available from: http://www.quasi-niere.de/index.php?lang=en.
6. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2004) 1-12
7. Chadban S.J., Briganti E.M., Kerr P.G., Dunstan D.W., Welborn T.A., Zimmet P.Z., et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 14 (2003) S131-S138
8. Glassock R., and Winearls C. An epidemic of chronic kidney disease: fact or fiction. Nephrol Dial Transplant 23 (2008) 1117-1121
9. Keith D.S., Nichols G.A., Gullion C.M., Brown J.B., and Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
10. Kalantar-Zadeh K., Kopple J.D., Block G., and Humphreys M.H. Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol 12 (2001) 2797-2806
11. Remuzzi G., Perico N., Macia M., and Ruggenenti P. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 99 (2005) S57-S65
12. Khwaja A., El Kossi M., Floege J., and El Nahas M. The management of CKD: a look into the future. Kidney Int 72 (2007) 1316-1323
13. Boor P., Sebeková K., Ostendorf T., and Floege J. Treatment targets in renal fibrosis. Nephrol Dial Transplant 22 (2007) 3391-3407
14. Chan W., Valerie K.C., and Chan J.C.M. Expression of insulin-like growth factor-1 in uremic rats: growth hormone resistance and nutritional intake. Kidney Int 43 (1993) 790-795
15. Tonshoff B., Schaefer F., and Mehls O. Disturbance of growth hormone-insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment. Pediatr Nephrol 4 (1990) 654-662
16. Rabkin R., Sun D.F., Chen Y., Tan J., and Schaefer F. Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatr Nephrol 20 (2005) 313-318
17. Iglesias P., Díez J.J., Fernández-Reyes M.J., Méndez J., Bajo M.A., Aguilera A., et al. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis. Clin Endocrinol (Oxf) 60 (2004) 741-749
18. Doi T., Striker L.J., Quaife C., Conti F.G., Palmiter R., Behringer R., et al. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol 131 (1988) 398-403
19. Mahesh S., and Kaskel F. Growth hormone axis in chronic kidney disease. Pediatr Nephrol 23 (2008) 41-48
20. Flyvbjerg A. The role of growth hormone in the pathogenesis of diabetic kidney disease. Pediatr Endocrinol Rev 1 Suppl 3 (2004) 525-529
21. Hammerman M.R. Insulin-like growth factor I treatment for end-stage renal disease at the end of the millennium. Curr Opin Nephrol Hypertens 9 (2000) 5-10
22. Kopple J.D. Dietary considerations in patients with chronic renal failure, acute renal failure, and transplantation. In: Schrier R.W. (Ed). Diseases of the kidney. 8th ed. (2006), Lippincott Williams & Wilkins, Philadelphia
23. Mehls O., Tonshoff B., Blum W.F., Heinrich U., and Seidel C. Growth hormone and insulin-like growth factor 1 in chronic renal failure-pathophysiology and rationale for growth hormone treatment. Acta Paediatr Scand Suppl 370 (1990) 28-34
24. Mitch W.E. Insights into the abnormalities of chronic renal disease attributed to malnutrition. J Am Soc Nephrol 13 Suppl 1 (2002) S22-S27
25. Ikizler T.A., Wingard R.L., and Hakim R.M. Interventions to treat malnutrition in dialysis patients: the role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone. Am J Kidney Dis 26 (1995) 256-265
26. Haffner D., Schaefer F., Girard J., Ritz E., and Mehls O. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J Clin Invest 93 (1994) 1163-1171
27. Sun D.F., Zheng Z., Tummala P., Oh J., Schaefer F., and Rabkin R. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle. J Am Soc Nephrol 15 (2004) 2630-2636
28. Ikizler T.A., and Hakim R.M. Nutrition in end-stage renal disease. Kidney Int 50 (1996) 343-357
29. Mehls O., Ritz E., Hunziker E.B., Eggli P., Heinrich U., and Zapf J. Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 33 (1988) 45-52
30. Garibotto G., Barreca A., Russo R., Sofia A., Araghi P., Cesarone A., et al. Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients. J Clin Invest 99 (1997) 97-105
31. Pupim L.B., Flakoll P.J., Levenhagen D.K., and Ikizler T.A. Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients. Am J Physiol Endocrinol Metab 286 (2004) E589-E597
32. Sesmilo G., Biller B.M., Llevadot J., Hayden D., Hanson G., Rifai N., et al. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133 (2000) 111-122
33. Deicher R., and Hörl W.H. Hormonal adjuvants for the treatment of renal anaemia. Eur J Clin Invest 35 Suppl 3 (2005) 75-84
34. Kinugawa S., Tsutsui H., Ide T., Nakamura R., Arimura K., Egashira K., et al. Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes. Cardiovasc Res 43 (1999) 157-164
35. Cho G., Jeong I., Kim S., Kim M., Park W., Oh D., et al. Effect of growth hormone on cardiac contractility in patients with adult onset growth hormone deficiency. Am J Cardiol 100 (2007) 1035-1039
36. Le Corvoisier P., Hittinger L., Chanson P., Montagne O., Macquin-Mavier I., and Maison P. Cardiac effects of growth hormone treatment in chronic heart failure: a meta-analysis. J Clin Endocrinol Metab 92 (2007) 180-185
37. Volterrani M., Manelli F., Cicoira M., Lorusso R., and Giustina A. Role of growth hormone in chronic heart failure. Therapeutic implications. Drugs 60 (2000) 711-719
38. Jehle P.M., Ostertag A., Schulten K., Schulz W., Jehle D.R., Stracke S., et al. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int 57 (2000) 423-436
39. Fouque D., Peng S.C., Shamir E., and Kopple J.D. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 57 (2000) 646-654
40. Kopple J.D., Brunori G., Leiserowitz M., and Fouque D. Growth hormone induces anabolism in malnourished maintenance hemodialysis patients. Nephrol Dial Transplant 20 (2005) 952-958
41. Hansen T.B., Gram J., Jensen P.B., Kristiansen J.H., Ekelund B., Christiansen J.S., et al. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Clin Nephrol 53 (2000) 99-107
42. Iglesias P., Diez J.J., Fernandez-Reyes M.J., Aguilera A., Burgués S., Martinez-Ara J., et al. Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study. Am J Kidney Dis 32 (1998) 454-463
43. Johannsson G., Bengtsson B.A., and Ahlmen J. Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement. Am J Kidney Dis 33 (1999) 709-717
44. Jensen P.B., Hansen T.B., Frystyk J., Ladefoged S.D., Pedersen F.B., and Christiansen J.S. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Clin Nephrol 52 (1999) 103-109
45. Kotzmann H., Yilmaz N., Lercher P., Riedl M., Schmidt A., Schuster E., et al. Differential effects of growth hormone therapy in malnourished hemodialysis patients. Kidney Int 60 (2001) 1578-1585
46. Feldt-Rasmussen B., Lange M., Sulowicz W., Gafter U., Lai K.N., Wiedeman J., et al. Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. J Am Soc Nephrol 18 (2007) 2161-2171
47. ™: a clinical trial to asses the effects of human growth hormone on outcomes in maintenance hemodialysis patients. Clin J Am Soc Nephrol 3 6 (2008) 1741-1751